Dissolvable magnesium stents under Real-World scrutiny in major registry
NCT ID NCT04679740
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry is tracking over 1,100 people with coronary artery disease who receive resorbable magnesium scaffolds—stents that slowly dissolve over time. The goal is to see how well these devices work in everyday medical practice, focusing on safety and whether they keep arteries open after one year. Participants are treated according to standard guidelines, with no extra restrictions beyond the device's instructions for use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Magmaris and Freesolve resorbable magnesium scaffolds (drug-eluting devices)
What this could lead to
If successful, this registry could confirm that resorbable magnesium scaffolds are a safe and effective option for opening blocked heart arteries, potentially reducing the need for permanent metal stents.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the scaffolds are better than existing treatments. Risks include scaffold failure, blood clots, or the need for repeat procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
1 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ w Lublinie
RECRUITINGLublin, Poland
Contact
-
Cairns Hospital
COMPLETEDCairns, 4870, Australia
-
Centre Hospitalier Universitaire Vaudois
RECRUITINGLausanne, 1005, Switzerland
Contact
-
Centro Cardiologico Monzino
RECRUITINGMilan, Lombardy, 20138, Italy
Contact
-
Daugavpils Regional Hospital
COMPLETEDDaugavpils, LV-5417, Latvia
-
Heart Center Segeberger Kliniken
RECRUITINGBad Segeberg, 23795, Germany
Contact
Contact
-
Herz-und Gefäßzentrum Oberallgäu-Kempten
COMPLETEDKempten, Germany
-
Klinikum Herford
COMPLETEDHerford, 32049, Germany
-
Klinikum Westfalen, Knappschaft KH
COMPLETEDDortmund, 44309, Germany
-
Krankenhaus Buchholz
COMPLETEDBuchholz, 21244, Germany
-
Lindenhofspital
RECRUITINGBern, 3001, Switzerland
Contact
-
SUSCCH Banska Bystrica
COMPLETEDBanská Bystrica, 974 01, Slovakia
-
Solothurner Spitäler AG
RECRUITINGOlten, 4600, Switzerland
Contact